| Home | E-Submission | Sitemap | Contact Us |  
J Korean Soc Ther Radiol > Volume 2(1); 1984 > Article
Journal of the Korean Society for Therapeutic Radiology 1984;2(1): 71-80.
Revaluation of Midline Malignant Reticulosis with Systemic Manifestation after Irradiation
G E Kim, C O Suh, B S Kim, W P Hong
Department of Radiology, Yonsei University, Yonsei Cancer Center, Korea.
During a 10 year periods, 42 patients with well-ocumented Midline Malignant Reticulosis were treated with local irradiation and followed for extended periods of time. 13 cases with systemic manifestation after irradiation illustrate the protean features of this disease. Although it commonly presents in upper airway tracts such as nasal cavity and/or septum, soft palate and palatine tonsil, the lesion may be localized as well as diffuse. 2 cases among them showed systemic relapse on lung, pancreas and scrotum probably from either a multifocal or metastatic deposits. Another 3 cases were associated with systemic diseases such as stomach carcinoma, typhoid enteritis and CNI of fat tissue. Remained cases were diagnosed by clinical or radiological examination. Possibility of close relation to lymphoma with Midline Malignant Reticulosis are also suggested in 1 case. In Midline Malignant Reticulosis, the best results of treatment are obtained in localized lesion of the upper airway treated early with irradiation: A poorer outcome is associated with multifocal systemic involvement, which necessitates a systemic therapy.
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
CrossRef TDM  CrossRef TDM
Related articles
Dose Attenuation in the Mid-Cranial Fossa with 6 MV hoton Beam Irradiations1990 June;8(1)
Radiotherapy Results of Midline Malignant Reticulosis (MMR)1996 December;14(4)
Editorial Office
Department of Radiation Oncology, Seoul National University Hospital,
Hamchun Hall, 6F, 95 Daehak-ro, Jongno-gu, Seoul 03082, Republic of Korea
Tel : +82-2-743-6574
E-mail: roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next